Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce product...
Leadership
Christopher R. Anzalone Ph.D.
Chairman, CEO & President
Daniel J. Apel
Chief Financial Officer
Patrick O'Brien J.D., PharmD
COO & Secretary
James C. Hamilton M.D., MBA
Chief Medical Officer and Head of R&D
Mark M. Davis Ph.D.Founder
Founder and Founder & Director of Insert Therapeutics Inc & Calando
